Chatham Capital Group, Inc. Merck & Co., Inc. Transaction History

Chatham Capital Group, Inc.

$583 Million
Q1 2025

A detailed history of Chatham Capital Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 32,887 shares of MRK stock, worth $2.95 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

32,887

Previous 32,568 0.98%

Holding current value

$2.95 Million

Previous $3.24 Million 8.89%

% of portfolio

0.51%

Previous 0.54%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	BUY	$83.01 - $101.02 $26,480 - $32,225	319 Added 0.98%	32,887 $2.95 Million
Q4 2024 Feb 06, 2025	BUY	$96.31 - $114.76 $58,941 - $70,233	612 Added 1.92%	32,568 $3.24 Million
Q3 2024 Oct 15, 2024	SELL	$111.15 - $128.97 $1.31 Million - $1.52 Million	-11,771 Reduced 26.92%	31,956 $3.63 Million
Q2 2024 Jul 15, 2024	SELL	$123.8 - $132.96 $64,995 - $69,804	-525 Reduced 1.19%	43,727 $5.41 Million
Q1 2024 Apr 17, 2024	SELL	$113.24 - $131.95 $25,365 - $29,556	-224 Reduced 0.5%	44,252 $5.84 Million
Q4 2023 Jan 19, 2024	BUY	$100.18 - $109.02 $13,524 - $14,717	135 Added 0.3%	44,476 $4.85 Million
Q3 2023 Oct 25, 2023	BUY	$102.95 - $114.33 $219,901 - $244,208	2,136 Added 5.06%	44,341 $4.56 Million
Q2 2023 Jul 13, 2023	BUY	$108.61 - $118.38 $20,092 - $21,900	185 Added 0.44%	42,205 $4.87 Million
Q1 2023 Apr 21, 2023	BUY	$102.94 - $114.86 $11,323 - $12,634	110 Added 0.26%	42,020 $4.47 Million
Q4 2022 Jan 31, 2023	SELL	$87.44 - $112.11 $11,629 - $14,910	-133 Reduced 0.32%	41,910 $4.65 Million
Q3 2022 Oct 28, 2022	BUY	$84.53 - $94.96 $64,580 - $72,549	764 Added 1.85%	42,043 $3.62 Million
Q2 2022 Aug 02, 2022	BUY	$83.49 - $94.64 $36,401 - $41,263	436 Added 1.07%	41,279 $3.76 Million
Q1 2022 Apr 21, 2022	BUY	$73.51 - $82.4 $8,086 - $9,064	110 Added 0.27%	40,843 $3.35 Million
Q4 2021 Feb 02, 2022	SELL	$72.28 - $90.54 $131,911 - $165,235	-1,825 Reduced 4.29%	40,733 $3.12 Million
Q3 2021 Oct 13, 2021	SELL	$71.68 - $78.83 $63,293 - $69,606	-883 Reduced 2.03%	42,558 $3.2 Million
Q2 2021 Jul 28, 2021	BUY	$70.31 - $77.77 $46,685 - $51,639	664 Added 1.55%	43,441 $3.38 Million
Q1 2021 Apr 29, 2021	BUY	$68.86 - $81.11 $28,576 - $33,660	415 Added 0.98%	42,777 $3.3 Million
Q4 2020 Jan 27, 2021	SELL	$71.77 - $79.65 $94,736 - $105,138	-1,320 Reduced 3.02%	42,362 $3.47 Million
Q3 2020 Oct 22, 2020	SELL	$73.18 - $82.95 $265,277 - $300,693	-3,625 Reduced 7.66%	43,682 $3.62 Million
Q2 2020 Jul 20, 2020	SELL	$70.42 - $80.13 $10,140 - $11,538	-144 Reduced 0.3%	47,307 $3.66 Million
Q1 2020 May 01, 2020	BUY	$63.36 - $87.82 $87,373 - $121,103	1,379 Added 2.99%	47,451 $3.65 Million
Q4 2019 Jan 31, 2020	BUY	$77.58 - $87.54 $9,309 - $10,504	120 Added 0.26%	46,072 $4.19 Million
Q3 2019 Nov 08, 2019	BUY	$76.08 - $82.93 $3,043 - $3,317	40 Added 0.09%	45,952 $3.87 Million
Q2 2019 Jul 24, 2019	BUY	$69.84 - $81.59 $3.21 Million - $3.75 Million	45,912 New	45,912 $3.85 Million

Others Institutions Holding MRK

# of Institutions

3,954

Shares Held

1.86B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chatham Capital Group, Inc. with notifications on news.

Account

Chatham Capital Group, Inc. Merck & Co., Inc. Transaction History